novo nordisk semaglutide products and competitors sued Eli Lilly, alleging misleading ads unfairly compare doses of Zepbound Mounjaro with Wegovy and Ozempic. Tap link in bio for full story Company of the Year 2024:

While these results must be treated with caution, the analysis shows semaglutide can be an effective tool to treat this advanced liver disease. The trials findings, published Wednesday in the New England Journal of Medicine, are almost certain to secure the drugs approval for treating MASH from the Food and Drug Administration

The longer intake and coaching framework can reduce side effects and improve adherence

If youre struggling with excess weight and traditional methods like diet and exercise havent worked for you, Tirzepatide weight loss treatment in PA may be a great option

A review describing GLP-1 drugs as promising but unproven for alcohol and substance use concludes that approved treatments should be used until safety and efficacy are demonstrated in dedicated trials